Mualliflar

  • Полвонов А.Ч., Хасанов А.И.
  • Нишанов Д.А.

##semicolon##

плеоморфная аденома; околоушная слюнная железа; иммуногистохимия; PLAG1; Ki-67; p63; CD34; опухоли слюнных желёз

##submission.citations##

1. Auclair P.L., Ellis G.L. Major and minor salivary glands: neoplasms // Mod Pathol. – 1996. – Vol. 9, № 6. – P. 634–649.

2. Bahrami A. et al. PLAG1 alteration in pleomorphic adenoma: a molecular marker // Mod Pathol. – 2012. – Vol. 25, № 6. – P. 819–831.

3. Burghout K.S.T., Breimer G.E., Koppes S. et al. Recurrent MDM2 amplification in the spectrum of HMGA2-altered pleomorphic adenoma, atypical pleomorphic adenoma and carcinoma ex pleomorphic adenoma // Head Neck Pathol. – 2025. – Vol. 19. – P. 53.

4. Cheuk W., Chan J.K.C. Salivary gland tumors: update on classification and immunohistochemistry // Arch Pathol Lab Med. – 2012. – Vol. 136, № 3. – P. 315–325.

5. Chiesa-Estomba C.M. et al. Management of recurrent pleomorphic adenoma of the parotid gland: a review // Eur Arch Otorhinolaryngol. – 2022. – Vol. 279, № 9. – P. 4285–4293.

6. Dardick I., van Nostrand A.W., Smout M.S. Myoepithelial cells in salivary gland tumors: recognition, morphology, and function // Pathol Annu. – 1987. – Vol. 22, Pt 1. – P. 113–157.

7. Fonseca F.P. et al. Immunohistochemical and molecular analysis of PLAG1 and HMGA2 in salivary gland tumors // Oral Surg Oral Med Oral Pathol Oral Radiol. – 2021. – Vol. 131, № 2. – P. 191–198.

8. Foote F.W., Frazell E.L. Tumors of the major salivary glands // Cancer. – 1954. – Vol. 7, № 6. – P. 843–856.

9. Geurts J.M., Schoenmakers E.F., Roijer E. et al. Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas // Oncogene. – 1998. – Vol. 16, № 7. – P. 865–872.

10. Gibbons D. et al. Lack of PLAG1 and HMGA2 rearrangements in a subset of morphologically typical pleomorphic adenomas: implications for diagnostics // Virchows Arch. – 2022. – Vol. 480, № 2. – P. 411–419.

11. Gnepp D.R. et al. WHO Classification of Head and Neck Tumours. 5th ed. – Lyon: IARC, 2021. Chapter: Salivary Gland Tumors.

12. Gondivkar S.M. et al. Pleomorphic adenoma: a comprehensive review // J Maxillofac Oral Surg. – 2020. – Vol. 19, № 2. – P. 312–317.

13. Görög B. et al. Lack of EBV/HPV genomes in pleomorphic adenomas using sensitive PCR techniques // Pathol Oncol Res. – 2022. – Vol. 28. – P. 161015.

14. Карапетян И.С. и соавт. Опухоли около–ушной слюнной железы // Рос. онк. журн. – 2004. – № 1. – С. 24–29.

15. Kas K., Voz M.L., Hensen K. et al. Transcriptional activation capacity of the novel PLAG family of zinc finger proteins // J Biol Chem. – 1998. – Vol. 273, № 38. – P. 23026–23032.

16. Katabi N., Ghossein R. Molecular pathology of salivary gland neoplasms: diagnostic and prognostic updates // Histopathology. – 2022. – Vol. 80, № 3. – P. 501–514.

17. Kleinsasser O., Brandt S. et al. Expression of PLAG1 in pleomorphic adenoma and carcinoma ex pleomorphic adenoma: an immunohistochemical study // Head Neck Pathol. – 2019. – Vol. 13, № 1. – P. 22–29.

18. Makarevich O. et al. EBNA-1 expression in pleomorphic adenoma: potential implications // J Oral Pathol Med. – 2021. – Vol. 50, № 9. – P. 853–861.

19. Marchiano E. et al. Association of Epstein-Barr virus with salivary gland tumors: a meta-analysis // Viruses. – 2021. – Vol. 13, № 6. – P. 1129.

20. Marchiano E. et al. Epstein-Barr virus detection in salivary gland neoplasms: a PCR and FISH analysis // Viruses. – 2021. – Vol. 13, № 6. – P. 1129.

21. Ogawa K. et al. Prognostic analysis of patients with carcinoma ex pleomorphic adenoma // Int J Clin Oncol. – 2023. – Vol. 28, № 2. – P. 290–299.

22. Persson F. et al. Recurrent fusion genes in salivary gland tumors // J Pathol. – 2009. – Vol. 217, № 5. – P. 445–456.

23. Sato T. et al. Ki-67 expression and tumor behavior in pleomorphic adenoma // Int J Clin Exp Pathol. – 2019. – Vol. 12, № 2. – P. 577–584.

24. Sato T. et al. SOX10 and p63 in salivary gland tumors: updated interpretation // Pathol Int. – 2023. – Vol. 73, № 2. – P. 83–91.

25. Seethala R.R., Wenig B.M. Surgical pathology of salivary gland tumors: update // Arch Pathol Lab Med. – 2022. – Vol. 146, № 6. – P. 681–691.

26. Seethala R.R. et al. Update from the 5th Edition WHO Classification of Head and Neck Tumors: Salivary Glands // Head Neck Pathol. – 2022. – Vol. 16, № 1. – P. 40–53.

27. Speight P.M., Barrett A.W. Salivary gland tumours // Oral Dis. – 2021. – Vol. 27, Suppl 1. – P. 18–28.

28. Subramaniam R.M. et al. Tumor microenvironment and VEGF expression in salivary gland tumors: potential roles in recurrence // Head Neck. – 2021. – Vol. 43, № 4. – P. 1013–1020.

29. Takimoto T. et al. CD34-positive stromal cells in pleomorphic adenoma and their correlation with recurrence // Histopathology. – 2022. – Vol. 80, № 3. – P. 432–440.

30. Tonon G. et al. Identification of HMGA2 rearrangements in pleomorphic adenoma // Cancer Genet. – 2021. – Vol. 254–255. – P. 42–49.

31. Vazquez A. et al. Detection of HPV and EBV in benign and malignant salivary gland tumors // Am J Clin Pathol. – 2020. – Vol. 153, № 3. – P. 321–327.

32. Wenig B.M. Salivary Gland Neoplasms // Gnepp's Diagnostic Surgical Pathology of the Head and Neck. 3rd ed. – Philadelphia: Elsevier, 2021. – P. 583–640.

33. Юсупов Б.Ю. Особенности распространения злокачественных опухолей глотки в Республике Узбекистан // Материалы I Конгресса онкологов Республики Узбекистан. – Ташкент, 2005. – С. 12–13.